Analysts Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) PT at $162.00

Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twenty-two research firms that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and nineteen have issued a buy recommendation on the company. The average […]

Leave a Reply

Your email address will not be published.

Previous post Verizon Communications Inc. (NYSE:VZ) Receives $47.41 Average Price Target from Brokerages
Next post Magna International Inc. (NYSE:MGA) Receives $41.56 Consensus Price Target from Analysts